Based on preclinical studies, we hypothesised that a combination of elevated NQO1 and low catalase (a detoxifying enzyme) in tumour specimens—reported as an elevated NQO1/catalase ratio—would provide the most meaningful predictor of efficacy.36 However, we were not able to reliably quantify tissue catalase expression in the available clinical samples. Here, CAT is linked to neoplasm.